Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
Cheng R.
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 1 到 9 筆資料,總共 9 筆
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2017
Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic review
Chen L.-T.; Oh D.-Y.; Ryu M.-H.; KUN-HUEI YEH
; Yeo W.; Carlesi R.; Cheng R.; Kim J.; Orlando M.; Kang Y.-K.
Cancer Research and Treatment
54
43
2018
Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting
Reck M.; Garassino M.C.; Imbimbo M.; Shepherd F.A.; Socinski M.A.; JIN-YUAN SHIH
; Tsao A.; Lee P.; Winfree K.B.; Sashegyi A.; Cheng R.; Varea R.; Levy B.; Garon E.
Lung Cancer
28
25
2020
Does pemetrexed work in targetable, nonsquamous non-small-cell lung cancer? A narrative review
JIN-YUAN SHIH
; Inoue A.; Cheng R.; Varea R.; Kim S.-W.
Cancers
11
9
2020
Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies
Yen C.-J.; Kudo M.; Lim H.-Y.; CHIH-HUNG HSU
; Vogel A.; Brandi G.; Cheng R.; Nitu I.S.; Abada P.; Hsu Y.; Zhu A.X.; Kang Y.-K.
Liver Cancer
12
10
2021
How may ramucirumab help improve treatment outcome for patients with gastrointestinal cancers?
Chen M.-H.; Lu S.-N.; CHIEN-HUNG CHEN
; Lin P.-C.; Jiang J.-K.; D’yachkova Y.; Lukanowski M.; Cheng R.; Chen L.-T.
Cancers
2
1
2021
An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast Cancer
YEN-SHEN LU
; Yeo W.; Yap Y.-S.; Park Y.H.; Tamura K.; Li H.; Cheng R.
Targeted Oncology
5
5
2013
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck cancer: Results of an exploratory subgroup analysis of a phase III trial
Urba S.; RUEY-LONG HONG
; Hossain A.M.; Cheng R.; Orlando M.
Asia-Pacific Journal of Clinical Oncology
1
1
2018
Ramucirumab safety in East Asian patients: A meta-analysis of six global, randomized, double-blind, placebo-controlled, phase III clinical trials
Yen C.-J.; Muro K.; Kim T.-W.; Kudo M.; JIN-YUAN SHIH
; Lee K.-W.; Chao Y.; Kim S.-W.; Yamazaki K.; Sohn J.; Cheng R.; Zhang Y.; Binder P.; Mi G.; Orlando M.; Chung H.C.
Journal of Global Oncology
9
0
2020
Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open-Label, Phase Ib Study
CHIA-CHI LIN
; Yang T.-S.; Yen C.-J.; Cheng R.; Liu J.; CHIUN HSU
Oncologist
5
4